A civil lawsuit that shifted into U.S. district court in Idaho last week alleges that the United Potato Growers of America has become a veritable OPEC of spuds. The group is accused of using high-tech, strong-arm tactics to inflate potato prices.
The ruling may end the era of what are also called "reverse-payment" deals, in which the maker of a brand-name drug pays a maker of generic drugs to not produce a lower-priced version of their product. The Federal Trade Commission can challenge such deals in court, the justices say.
The birthday song — Happy birthday to you, happy birthday to you, etc. — is still under copyright protection. That may soon change.
The Supreme Court sided with government regulators in an important case involving the pharmaceutical industry and patent law. At issue were contracts between "brand-name" pharmaceutical companies and "generic" producers in which the brand-name company paid the generic not to compete. The court said the Federal Trade Commission could challenge such contracts.
Google's "Project Loon" just launched in New Zealand — it uses balloons floating in the stratosphere to bring high-speed Internet access to remote areas.
- For People Of Color, A Housing Market Partially Hidden From View |
- Italian University Spreads The 'Gelato Gospel' |
- Economists To G-8: Want Growth? Try This |
- Lowes Looks To Acquire Hardware Stores |
- Mind-Numbing TV Shows Are A Hit In Norway |
- Smartphones Help Bridge Gaps In Electronic Medical Records |
- Poor Economy Encourages Scientists To Leave Spain |
- Long-Term Interest Rates Start Moving Higher |
- To Find Out How The Health Law Affects You, Ask The President |
- Visa Exchange Program Draws Scrutiny Under Immigration Bill |